My Market Wizard

ALTERITY THERAPEUTICS LTD 6-K Analysis & Summary – 3/14/2025

⚠️This is not investment advice.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️

Alterity Therapeutics Limited

Filing date:

03/14/2025

TLDR:

JPMorgan Chase & Co. became a substantial holder in Alterity Therapeutics Ltd, acquiring a 5.13% voting power.

ELI5:

JPMorgan Chase & Co. now owns a significant portion (over 5%) of Alterity Therapeutics, a company listed on the stock market. This means they have a say in how the company is run.

Accession #:

0001013762-25-000319

Published on

Analyst Summary

  • JPMorgan Chase & Co. and its affiliates have become substantial holders in Alterity Therapeutics Ltd.
  • The total voting power held by JPMorgan Chase & Co. is 5.13%, represented by 341,554,014 ordinary shares.
  • The substantial holding was established on March 11, 2025.
  • Relevant interests are held through various entities including JPMORGAN CHASE BANK, N.A., J.P. MORGAN SECURITIES LLC, and J.P. MORGAN SECURITIES AUSTRALIA LIMITED.
  • The holdings include securities on loan, rehypothecated client securities, and securities held in a principal/proprietary capacity.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️